Newsfiscal.ai
Inovio Pharmaceuticals Secures $80.4 Million Judgment in Litigation Against VGXI and GeneOne
· Published
Article summary
Inovio Pharmaceuticals, Inc. announced a favorable legal judgment totaling $80.4 million against VGXI, Inc. and GeneOne Life Science, though the company cautioned that collection remains uncertain.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…